VAERS reports by lot

GSK DTaP/Tdap lot D24G7: VAERS reports

56 VAERS reports list lot D24G7 as a GSK DTaP/Tdap vaccine, received between 2020-09-21 and 2022-12-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
0%
Marked serious
0
With a death outcome
20
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3876%
Allergic / Anaphylactic48%
Neurological24%
Respiratory24%
General / Systemic (non-local)24%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana9
California6
Texas3
Wisconsin3
Oregon2
Florida2
Iowa2
Rhode Island2
Missouri2
Arkansas2
Georgia1
Maryland1

Reports by month received

2020-092
2020-102
2020-112
2020-122
2021-013
2021-022
2021-031
2021-044
2021-052
2021-066
2021-079
2021-081
2021-101
2021-111
2022-022
2022-032
2022-052
2022-065
2022-075
2022-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.